Is This Christmas Plant the Secret to Beating Cancer?

Mistletoe has long been associated with the holiday season, but few people know its rich history and powerful potential in integrative oncology. In this episode of Prescribed by Dr. Nathan Goodyear, we explore the science and practical applications of mistletoe therapy in cancer treatment. Join Dr. Goodyear and Dr. Miranda LaBant as they discuss the research, mechanisms of action, and innovative ways mistletoe is being used to transform patient outcomes in oncology.

Take Action
Learn More from Dr. LaBant at https://drmirandalabant.com/
Find more cancer care resources at https://pre-scribed.com/
Watch Part 2 Now!

The Medicinal Potential of Mistletoe
Mistletoe, a semi-parasitic plant, has been used for centuries in folk medicine for its therapeutic properties. In modern integrative oncology, mistletoe therapy has gained recognition for its immune-modulating, cytotoxic, and anti-inflammatory effects. With over 7,000 research publications, mistletoe is one of the most well-studied natural remedies in cancer care.

What You’ll Learn in This Episode:

1. Historical and Cultural Roots: Mistletoe has been documented in folklore and traditional medicine for thousands of years, with its earliest references dating back to the Druids. It has since evolved from a folk remedy into a highly researched therapeutic agent in integrative oncology.

2. Types of Mistletoe: While there are over 1,200 species of mistletoe, only a few are used in medicine. European mistletoe (Viscum album), American mistletoe (Phoradendron leucarpum), and dwarf mistletoe (Arceuthobium spp.) have been studied extensively for their medicinal properties. In clinical practice, Viscum album is the most commonly used species for cancer therapy.

3. Extraction Methods: The method of extraction significantly impacts the effectiveness of mistletoe therapy. The four main extraction techniques are:

- Iskador Method: A fermented extraction process that enhances bioavailability.

- Abnoba Method: A cold extraction that preserves sensitive compounds like lectins and viscotoxins.

- Viscum Method: An aqueous extraction focusing on purity.

- Helixor Method: A cold maceration process that maintains the balance of bioactive components.

4. Mechanisms of Action:
- Immune Modulation: Mistletoe stimulates the immune system by increasing the activity and number of dendritic cells, natural killer cells, and lymphocytes. It also boosts cytokine production, enhancing the body’s natural defenses against cancer.

- Cytotoxic Effects: Mistletoe induces apoptosis (programmed cell death) in cancer cells and inhibits tumor growth by stabilizing DNA and reducing inflammation.

- Tumor Inhibition: By targeting pathways like COX-2 and VEGF, mistletoe suppresses cancer metastasis and angiogenesis (the formation of new blood vessels that feed tumors).

5. Clinical Applications:
- Subcutaneous Injections: A common delivery method that provides chronic immune stimulation. Patients can be trained to administer these injections at home.

- Intravenous Therapy: Offers a more intensive systemic approach, often used as an adjunct to chemotherapy.

- Intratumoral Therapy: Directly targets tumors, enhancing local immune responses and reducing systemic side effects.

- Intravesical Therapy: Used in bladder cancer treatment, demonstrating success in reducing recurrence rates.

6. Research Highlights:
- A German study in 2023 showed that mistletoe therapy combined with chemotherapy and hyperthermia doubled the overall survival rate in pancreatic cancer patients compared to chemotherapy alone.

- A Phase I trial at Johns Hopkins University in 2021 confirmed the safety of intravenous mistletoe, showing improved quality of life and disease control in advanced cancer patients.

Timestamps
00:00 Introduction to Integrative Oncology and Mistletoe
03:06 The Medicinal Value of Mistletoe
05:57 Understanding Mistletoe as a Folk Remedy
09:11 Types of Mistletoe and Their Applications
12:01 Mistletoe in Clinical Practice and Research
15:12 The Role of Mistletoe in Cancer Treatment
17:49 Immunotherapy and Mistletoe's Mechanisms
20:45 Research Findings on Mistletoe and Cancer
23:48 Complexities of Mistletoe Therapy
25:23 Understanding Mistletoe Extraction Methods
30:36 Mechanisms of Action in Mistletoe Therapy
35:51 Precision Cancer Care and Mistletoe
39:08 Intratumoral Approaches to Mistletoe Therapy
47:31 Future Directions in Mistletoe Research

Sources Cited in This Episode:
Wode K, et al. “Mistletoe Extract in Patients With Advanced Pancreatic Cancer: A Double-Blind, Randomized, Placebo-Controlled Trial.” Dtsch Arztebl Int. 2024 May 31;121(11):347-354. DOI:10.3238/arztebl.m2024.0080

Paller CJ, et al. “Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.” Cancer Res Commun. 2023 Feb 28;3(2):338-346. DOI:10.1158/2767-9764.CRC-23-0002

Wode K, et al. “Mistletoe Therapy and Its Impact on Immune Modulation and Quality of Life in Cancer Patients.” Integrative Cancer Therapies. 2023.